It has been demonstrated that metastatic PTC is regulated by estrogen and the functional estrogen receptor (ER), enhancing the migratory, invasive, and proliferative phenotypes of cancer cells, as it does in other cancers such as breast cancer [23]. Here, ESR1 is linked to breast carcinoma.